loading

Iovance Biotherapeutics Inc (IOVA) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
기간 3개월 3개월 3개월 3개월 3개월
Revenues
39.04%
99.31
71.43 86.77 67.45 59.95
Cost Of Revenue
2.58%
43.59
42.50 43.11 38.48 56.66
Research and Development
5.82%
58.85
62.49 71.20 - -
Costs And Expenses
0.82%
151.22
152.47 160.23 162.36 173.73
Depreciation and Amortization
11.25%
9.50
8.539 9.517 9.007 -
Operating Income/Loss
35.95%
-51.91
-81.04 -73.46 -94.90 -113.77
Income/Loss From Continuing Operations Before Tax
38.92%
-48.69
-79.71 -71.72 -93.66 -109.67
Income Tax Expense/Benefit, Deferred
106.47%
-1.373
-0.665 0.184 -2.405 1.988
Income Tax Expense/Benefit
106.47%
-1.373
-0.665 0.184 -2.405 1.988
Net Income/Loss
40.14%
-47.31
-79.05 -71.90 -91.25 -111.66
Basic Average Shares
7.57%
0.4502
0.4185 - 0.364 0.3345
Diluted Average Shares
7.57%
0.4502
0.4185 - - 0.3345
Basic Earnings Per Share
42.11%
-0.11
-0.19 - -0.25 -0.33
Diluted Earnings Per Share
42.11%
-0.11
-0.19 - - -0.33
$86.17
price down icon 2.05%
$295.54
price down icon 0.99%
$142.78
price down icon 6.45%
$241.76
price down icon 2.61%
$26.73
price down icon 2.84%
KOD KOD
$85.75
price down icon 2.69%
자본화:     |  볼륨(24시간):